XML 62 R41.htm IDEA: XBRL DOCUMENT v2.4.1.9
OTHER CURRENT LIABILITIES (Details) (USD $)
Mar. 31, 2015
Dec. 31, 2014
Other Liabilities Disclosure [Abstract]    
Accrued clinical trial costs $ 2,672,962txmd_AccruedClinicalTrialCostsCurrent $ 1,706,542txmd_AccruedClinicalTrialCostsCurrent
Accrued payroll, bonuses and commission costs 900,662us-gaap_AccruedSalariesCurrent 814,205us-gaap_AccruedSalariesCurrent
Accrued vacation costs 429,740us-gaap_AccruedVacationCurrent 442,430us-gaap_AccruedVacationCurrent
Accrued legal and accounting expense 114,760us-gaap_AccruedProfessionalFeesCurrent 276,470us-gaap_AccruedProfessionalFeesCurrent
Other accrued expenses 312,181us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent [1] 185,965us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent [1]
Allowance for wholesale distributor fees 121,469txmd_AllowanceForWholesaleDistributorFeesCurrent 160,503txmd_AllowanceForWholesaleDistributorFeesCurrent
Accrued royalties 53,415us-gaap_AccruedRoyaltiesCurrent 72,710us-gaap_AccruedRoyaltiesCurrent
Allowance for coupons and returns 184,521txmd_SalesDiscountsReturnsAndAllowancesGoods1 90,446txmd_SalesDiscountsReturnsAndAllowancesGoods1
Accrued rent 89,742us-gaap_AccruedRentCurrent 91,368us-gaap_AccruedRentCurrent
TOTAL OTHER CURRENT LIABILITIES $ 4,879,452us-gaap_OtherLiabilitiesCurrent $ 3,840,639us-gaap_OtherLiabilitiesCurrent
[1] In June 2008, we declared and paid a special dividend of $0.40 per share of our Common Stock to all stockholders of record as of June 10, 2008, of which $41,359 remained unclaimed by certain shareholders at March 31, 2015 and December 31, 2014.